Skip to content
ClinCalc Pro
Menu
Emergency Medicine Toxicology Strong — MHRA and NPIS recommended treatment threshold

Rumack-Matthew Nomogram

Determines need for N-acetylcysteine (NAC) treatment following paracetamol (acetaminophen) overdose based on serum level and time post-ingestion

Used in: Poisoning & Overdose

mg/L — if your laboratory reports µmol/L, divide by 6.62

Score interpretation

Level Taken Under 4 Hours — Cannot Be Interpreted -1

A paracetamol level taken less than 4 hours after ingestion cannot be plotted on the treatment line.

→ Repeat the level at 4 hours or later after ingestion; follow TOXBASE for when to start treatment before the level.

Below Treatment Line 0

Level below the UK single treatment line (100 mg/L at 4 h, 15 mg/L at 15 h) for the time since ingestion.

→ Acetylcysteine not indicated by the line. Clinical review — if ALT is raised or the patient has symptoms, follow TOXBASE.

On or Above Treatment Line — Acetylcysteine Indicated 1

Level on or above the UK single treatment line (MHRA 2012: treat regardless of risk factors).

→ Start intravenous acetylcysteine per TOXBASE / local protocol. Check INR, ALT, creatinine and acid–base; seek National Poisons Information Service advice if needed (UK: 0344 892 0111).

Treatment Line Not Applicable — Staggered or Uncertain Timing 2

The treatment line cannot be used for a staggered overdose or when the time of ingestion is uncertain (MHRA 2012).

→ Treat per TOXBASE / National Poisons Information Service guidance.

Interpretation bands for the Rumack-Matthew. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

The Rumack-Matthew is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.